{{Rsnum
|rsid=11666377
|Gene=CPAMD8
|Chromosome=19
|position=17007623
|Orientation=plus
|GMAF=0.1552
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CPAMD8
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 72.7 | 25.5 | 1.8
| HCB | 81.6 | 17.6 | 0.7
| JPT | 86.7 | 13.3 | 0.0
| YRI | 39.5 | 46.9 | 13.6
| ASW | 54.4 | 42.1 | 3.5
| CHB | 81.6 | 17.6 | 0.7
| CHD | 79.0 | 20.0 | 1.0
| GIH | 82.2 | 16.8 | 1.0
| LWK | 53.6 | 37.3 | 9.1
| MEX | 81.0 | 19.0 | 0.0
| MKK | 48.7 | 46.7 | 4.7
| TSI | 76.5 | 21.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Brain lesion load
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000007
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs11666377
|Name_s=
|Gene_s=CPAMD8
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 791 cases, 883 controls; Replication Sample Size: NR); (Region: 19p13.11; Reported Gene(s): CPAMD8; Risk Allele: rs11666377-?); (p-value= 0.000007).This variant is associated with Brain lesion load.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740336
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11666377
|overall_frequency_n=27
|overall_frequency_d=128
|overall_frequency=0.210938
|n_genomes=21
|n_genomes_annotated=0
|n_haplomes=26
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}